Dysregulated Expression of Inflammasome and Extracellular Matrix Genes in C9orf72-ALS/FTD Microglia
- PMID: 40776416
- DOI: 10.1080/17590914.2025.2542998
Dysregulated Expression of Inflammasome and Extracellular Matrix Genes in C9orf72-ALS/FTD Microglia
Abstract
Hexanucleotide repeat expansion (HRE) in the non-coding region of the gene C9orf72 is the most prevalent mutation in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The C9orf72 HRE contributes to neuron degeneration in ALS/FTD through both cell-autonomous mechanisms and non-cell autonomous disease processes involving glial cells such as microglia. The molecular mechanisms underlying the contribution of C9orf72-HRE microglia to neuron death in ALS/FTD remain to be fully elucidated. In this study, we generated microglia from human C9orf72-HRE and isogenic iPSCs using three different microglia derivation methods. RNA sequencing analysis reveals a cell-autonomous dysregulation of extracellular matrix (ECM) genes and genes involved in pathways underlying inflammasome activation in C9orf72-HRE microglia. In agreement with elevated expression of inflammasome components, conditioned media from C9orf72-HRE microglia enhance the death of C9orf72-HRE motor neurons implicating microglia-secreted molecules in non-cell autonomous mechanisms of C9orf72 HRE pathology. These findings suggest that aberrant activation of inflammasome-mediated mechanisms in C9orf72-HRE microglia results in a pro-inflammatory phenotype that contributes to non-cell autonomous mechanisms of motor neuron degeneration in ALS/FTD.
Keywords: Amyotrophic lateral sclerosis; C9orf72; RNA sequencing; extracellular matrix; inflammasome; microglia.
Similar articles
-
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids.Acta Neuropathol Commun. 2024 Sep 18;12(1):152. doi: 10.1186/s40478-024-01857-1. Acta Neuropathol Commun. 2024. PMID: 39289761 Free PMC article.
-
Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.Mol Neurobiol. 2023 Jul;60(7):4004-4016. doi: 10.1007/s12035-023-03315-w. Epub 2023 Apr 3. Mol Neurobiol. 2023. PMID: 37010807
-
A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in an AAV-C9ORF72 (G4C2)66 mouse model.Acta Neuropathol Commun. 2024 Dec 26;12(1):203. doi: 10.1186/s40478-024-01911-y. Acta Neuropathol Commun. 2024. PMID: 39722074 Free PMC article.
-
Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD - a Systematic Review and Meta-Analysis.Cerebellum. 2022 Aug;21(4):681-714. doi: 10.1007/s12311-021-01320-0. Epub 2021 Sep 7. Cerebellum. 2022. PMID: 34491551 Free PMC article.
-
Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review.Neuropathol Appl Neurobiol. 2016 Oct;42(6):547-60. doi: 10.1111/nan.12284. Neuropathol Appl Neurobiol. 2016. PMID: 26373655
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous